0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Off-Center Fold |  April 01, 2013
Nodules on the Legs in a Renal Transplant Recipient—Diagnosis
JAMA Dermatol. 2013;149(4):475-480. doi:10.1001/jamadermatol.2013.2129b.
The Best of the Best |  February 01, 2013 FREE
Top-Accessed Article: Topical Rapamycin
Anita N. Haggstrom, MD; Stephen E. Wolverton, MD
JAMA Dermatol. 2013;149(2):203. doi:10.1001/jamadermatol.2013.750.
Correspondence |  February 01, 2013
Vein of Galen Malformation With Cutaneous Signs
Jamie Zussman, MD; Noriko Salamon, MD; Ki-Young Suh, MD
JAMA Dermatol. 2013;149(2):249-250. doi:10.1001/jamadermatol.2013.859.
Correspondence |  January 01, 2012
A Novel Application of Topical Rapamycin Formulation, an Inhibitor of mTOR, for Patients With Hypomelanotic Macules in Tuberous Sclerosis Complex
Mari Wataya-Kaneda, MD, PhD; Mari Tanaka, MD; Ayumi Nakamura, BPharm; et al.
Arch Dermatol. 2012;148(1):138-139. doi:10.1001/archderm.148.1.138.
Correspondence |  September 01, 2011
Dramatic Improvement of Facial Angiofibromas in Tuberous Sclerosis With Topical Rapamycin: Optimizing a Treatment Protocol
Cynthia M. C. DeKlotz, MD; Alicia E. Ogram, MD; Saurabh Singh, MD; et al.
Arch Dermatol. 2011;147(9):1117-1118. doi:10.1001/archdermatol.2011.254.
The Cutting Edge |  July 01, 2010 FREE
Topical Rapamycin:  A Novel Approach to Facial Angiofibromas in Tuberous Sclerosis
Anna K. Haemel, MD; Amy L. O’Brian, MD; Joyce M. Teng, MD, PhD
Arch Dermatol. 2010;146(7):715-718. doi:10.1001/archdermatol.2010.125.
Study |  August 01, 2009 FREE
Predictive Value of Café au Lait Macules at Initial Consultation in the Diagnosis of Neurofibromatosis Type 1
Kara S. Nunley, MD; Feng Gao, MD, PhD; Anne C. Albers, RN, MSN; et al.
Arch Dermatol. 2009;145(8):883-887. doi:10.1001/archdermatol.2009.169.
Review |  March 01, 2005 FREE
Phacomatosis Pigmentovascularis Revisited and Reclassified
Rudolf Happle, MD
Arch Dermatol. 2005;141(3):385-388. doi:10.1001/archpedi.161.4.356.
Editorial |  January 01, 2005
Screening School-aged Children for Neurofibromatosis 1:  Dermatology or Economics and Public Policy?
Vincent M. Riccardi, MD
Arch Dermatol. 2005;141(1):78-79. doi:10.1001/archderm.141.1.78.
Study |  January 01, 2005 FREE
Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment
Marga Lammert, MD; Jan M. Friedman, MD; Lan Kluwe, PhD; et al.
Arch Dermatol. 2005;141(1):71-74. doi:10.1001/archderm.141.1.71.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Images in Neurology  |  March 11, 2013
Pulsating Enophthalmos in Neurofibromatosis 1
Alexander Lehn, MD; Caroline Airey, MBBS; Richard Boyle, FRACP
JAMA Ophthalmology
Small Case Series  |  March 28, 2013
Failure of Systemic Propranolol Therapy for Choroidal Hemangioma of Sturge-Weber Syndrome:  A Report of 2 Cases
Hatem Krema, MD, FRCSEd; Yacoub A. Yousef, MD; Priya Durairaj, MD; et al.
JAMA Neurology
Images in Neurology  |  February 18, 2013
Symptomatic Neurocutaneous Melanosis in a Child
Puneet Jain, MD; Lakshminarayanan Kannan, MD; Atin Kumar, MD; et al.
JAMA Neurology
Clinical Pathologic Conference  |  February 25, 2013
Progressive Leg Pain and Weakness
Digvijaya D. Navalkele, MD; Maria-Magdalena Georgescu, MD; Dennis K. Burns, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems